Bridge Biotherapeutics, Inc. is a virtually-operated, venture-backed
clinical stage global biotech company, headquartered in Seongnam, Korea
with its subsidiary at JLABS@TMC, engaged in the development of novel therapeutics,
focusing on therapeutic areas of high unmet medical needs,
such as ulcerative colitis, fibrotic diseases, and cancers.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.